Find Academic Supervisors

Foteini Mourkioti is an Associate Professor at the University of Pennsylvania's Perelman School of Medicine , with a joint appointment in the Graduate Groups of Cell and Molecular Biology and Bioengineering . She co-directs the Musculoskeletal Regeneration Program at the Penn Institute of Regenerative Medicine and leads the McKay Orthopaedic Research Laboratory . Research Interests : Muscle Stem Cell Biology Mechanobiology Muscle Regeneration Telomere Biology in Muscular Diseases Fibrodysplasia Ossificans Progressiva (FOP) Cardiomyopathy and Aging Key Research Contributions : Developed the Pax7EGFP mouse model for real-time muscle stem cell tracking Discovered telomere shortening as a critical factor in Duchenne Muscular Dystrophy Elucidated the role of NF-κB in muscle stem cell dysfunction Identified Piezo1's role in stem cell morphological states Characterized fibro-adipogenic progenitor dynamics in FOP Scientific Awards : NIH/NHLBI R01 grant recipient (2019) NASA grant awardee (2020, 2017) American Heart Association grant (2017) Muscular Dystrophy Association grant (2019) University Research Foundation grant (2018) Publications & Collaborations : Over 25 publications in high-impact journals like Science Advances , Nature Protocols , and Cell Reports . Collaborates with Penn Cardiovascular Institute and Pennsylvania Muscle Institute.

• Muscle Stem Cell Biology
• Mechanobiology
• Aging
• +7 more

Edward Ashworth is a Postdoctoral Research Associate at the Sydney School of Health Sciences, University of Sydney. He is affiliated with the Thermal Ergonomics Laboratory and the Heat and Health Research Incubator. His research focuses on human adaptations to extreme environments, including heat, altitude, hyperbaric conditions, and space-related stressors. Key projects include improving sleep quality in hot environments and enhancing physical work capacity for outdoor workers. Edward's research interests span environmental physiology, with a focus on thermal tolerance, radiation injury mitigation, and the physiological effects of extreme conditions. He has contributed to studies involving nitrogen kinetics tracking using PET imaging, hyperbaric oxygen therapy, and robotic surgery applications. Awards: Young Investigator Award (2023), Art of Science Contest 1st Prize (2024), Australia Space Biology Summit 1st Place (2022), and Sporting Blue (Auckland University of Technology). Associations: The Physiological Society and American Physiological Society. His work integrates clinical trials, statistical research design, and translational approaches to address challenges in environmental health, cardiovascular disease, and healthy ageing. Current projects aim to optimize thermal tolerance strategies for military and occupational settings.

• Extreme Environmental Physiology
• Human Adaptation to Stressful Environments
• Environmental Health
• +3 more

Dr. Carla Vilela is an Assistant Professor in the Department of Chemistry at the University of Aveiro and Principal Researcher at CICECO. She coordinates the Sustainable Materials research line and leads projects on cellulose-based materials and circular economy. Her research focuses on sustainable materials from cellulose and renewable resources for applications in water remediation, food packaging, and textiles. Education includes a PhD in Chemistry from the University of Aveiro and postdoctoral work at CICECO and ISIS Neutron and Muon Source (UK). Research interests include: Development of cellulose-based functional materials Nanocomposites for biomedical applications Sustainable packaging solutions Biopolymer modification and characterization Publications demonstrate strong focus on cellulose nanocomposites, bioprinting bioinks, and active packaging. Recent articles frequently involve nanocellulose modifications, drug delivery systems, and sustainable material design. Awards include being named among World's Top 2% Scientists annually since 2020. Funding includes national projects (Cell4Janus) and EU collaborations (PRIMA Im-Pack). Leads the BioPol4Fun research group and supervises 6 PhD students. Current projects explore cellulose-based microrobots, resin valorization, and marine biopolymers.

• Sustainable Materials
• Cellulose Nanocomposites
• Biopolymers
• +2 more

Behnaam Aazhang is the J.S. Abercrombie Professor of Electrical and Computer Engineering at Rice University and Director of the Rice Neuroengineering Initiative (NEI). He holds a B.S., M.S., and Ph.D. from the University of Illinois at Urbana-Champaign. His roles include leading the multi-university Rice Neuroengineering Initiative and directing the Center for Neuroengineering. He has held an Academy of Finland Distinguished Visiting Professorship (FiDiPro) at the University of Oulu (2006-2014) and received an Honorary Doctorate from the University of Oulu in 2017. Education: Ph.D. in Electrical Engineering, University of Illinois at Urbana-Champaign (1986) M.S. in Electrical Engineering, University of Illinois at Urbana-Champaign (1983) B.S. in Electrical Engineering, University of Illinois at Urbana-Champaign (1981) Research Interests: Dr. Aazhang’s work focuses on signal/data processing, information theory, and neuroengineering applications. Key areas include: Neuronal circuit connectivity and learning impacts Real-time closed-loop neuromodulation for neurological disorders (epilepsy, Parkinson’s, depression) Patient-specific cardiac pacing systems Cybersecurity in cloud computing Awards & Honors: 2022 Rice Outstanding Doctoral Thesis Advisor Award 2019 SIGMOBILE Test of Time Award 2017 Honorary Doctorate (University of Oulu) 2013 IEEE Communication Society Advances in Communication Award AAAS and IEEE Fellowships (2012 and 1999) Grants & Advising: His research is supported by multi-university collaborations and grants. He has advised numerous graduate students in electrical engineering and neuroengineering, though specific names are not listed here. Labs & Teams: Leads the Aazhang Lab and the Rice Neuroengineering Initiative, focusing on translational technologies for neurological and cardiac disorders, including non-invasive neuromodulation and cloud security systems.

• Signal and Data Processing
• Information Theory
• Neuroengineering
• +4 more

Associate Professor Arnold Lining Ju is a biomedical engineer at the University of Sydney's School of Biomedical Engineering, affiliated with multiple institutes including the Heart Research Institute and Sydney Nano Institute. He holds academic positions in both the Faculty of Engineering and Faculty of Medicine & Health. Education: BSc from Peking University, PhD from Georgia Tech and Emory University (USA). Honors include Snow Fellowship, Heart Foundation Future Leader Fellowship, and multiple awards for cardiovascular research innovation. Research focuses on mechanobiology and biomechanics of thrombosis, developing microfluidic devices and organ-on-chip systems. Key projects include AI-driven single-cell nanotools, 3D biofabrication, and anti-thrombotic peptide design. Leads interdisciplinary teams and collaborates internationally with institutions like Harvard and University of Texas. Teaching roles include coordinating advanced cellular biomechanics courses and supervising PhD/Masters students in biomedical engineering and physiology. Over 50 peer-reviewed publications, with contributions to Nature Materials, Nature Communications, and other top journals.

• Mechanobiology
• Biomechanics
• Organ-on-chip
• +5 more

Dr. Markus Brinkmann is an Associate Professor in the School of Environment and Sustainability at the University of Saskatchewan, Canada, and Director of the Toxicology Centre. He holds the Centennial Enhancement Chair in Mechanistic Environmental Toxicology. His research focuses on exposure and risk assessment modeling, toxicokinetic modeling, and aquatic ecotoxicology, with an emphasis on understanding contaminant effects under realistic environmental conditions. Affiliations: Associate Professor, University of Saskatchewan Director, Toxicology Centre Member, Global Water Futures Program Member, Global Institute for Water Security Education: Ph.D. (Biology) - RWTH Aachen University, Germany (2015) M.Sc. (Ecotoxicology) - RWTH Aachen University, Germany (2011) B.Sc. (Biology) - RWTH Aachen University, Germany (2009) Research Interests: Dr. Brinkmann develops computational models to predict contaminant uptake, effects, and cross-species extrapolation. His work integrates toxicology, environmental chemistry, and hydrology to address challenges like flood-related contaminant remobilization and dioxin-like compound toxicity. Key areas include: Mechanistic toxicology of emerging contaminants (e.g., 6PPD-quinone, PFAS alternatives) Sediment toxicity and bioavailability Wastewater surveillance for public health monitoring Grant Highlights: Global Water Futures Program (2018-2023): Hydrological-exposure models for environmental risk assessment Genome Canada (2016-2020): EcoToxChip for chemical prioritization Banting Postdoctoral Fellowship (2016-2018) Awards: Friedrich-Wilhelm-Award (2016) SETAC GLB Young Scientists Award (2016 PhD, 2012 MSc) Borchers medal (2016) Leadership: He advises on strategic research partnerships between Canada and Germany and collaborates globally on projects like the EcoToxChip and Project House Water . His work bridges academic research with practical environmental management solutions.

• Exposure and risk assessment modelling
• Toxicokinetic modelling
• Aquatic ecotoxicology
• +3 more

Kristina Schoonjans is an Associate Professor at EPFL’s School of Life Sciences, where she leads the Laboratory of Metabolic Signaling (UPSCHOONJANS). Her research focuses on the molecular mechanisms of bile acid signaling, nutrient sensing, and intermediary metabolism, particularly in the context of metabolic disorders such as obesity, fatty liver disease, and cancer. She investigates how the liver-gut-brain axis integrates metabolic signals through nuclear receptors and mitochondrial dynamics. Her research interests include: Bile acid signaling and its role as a hormonal regulator Nutrient and metabolite sensing in energy homeostasis Intermediary metabolism and metabolic disorders Role of nuclear receptors (e.g., TGR5, LRH-1) in liver, gut, and adipose tissue Mitochondrial dynamics and fission in metabolic regulation Organoid models for studying liver and intestinal metabolism Systems genetics using BXD mouse populations The most recent articles highlight a strong focus on bile acid signaling, particularly through TGR5 and LRH-1, in regulating metabolic health. Themes include the conversion of white fat to beige fat (beiging), hepatic tumorigenesis, mitochondrial fission, and the use of organoid and genetically engineered mouse models. There is a consistent emphasis on translational applications for obesity, fatty liver disease, and cancer. Scientific honors include: Windaus Prize from the Dr. Falk Foundation (2010, shared with Johan Auwerx) for the discovery of the signaling/endocrine function of bile acids Prof. Schoonjans actively supervises PhD students and has advised numerous doctoral candidates who have since completed their theses. Her lab is supported by multiple grants from Swiss and international funding agencies, including the Swiss National Science Foundation, EPFL, CONACYT, and the Foundation for Health and Education. She teaches in several doctoral programs at EPFL, including Life Sciences Engineering, and contributes to education through the SSV and EDBB/EDCB/EDMS-ENS programs. The Schoonjans Lab brings together scientists, doctoral assistants, and technicians working on projects related to metabolic signaling. The team uses advanced techniques such as genetically modified mouse models, organoid cultures, and multi-omics (metabolomics, proteomics, transcriptomics) to study the liver-gut and brain-liver axes. The lab has a strong track record of high-impact publications and collaborations with institutions worldwide.

• Bile acid signaling
• Nutrient sensing
• Intermediary metabolism
• +11 more

Prof. Andreas Bausch holds the Heinz Nixdorf Endowed Chair of Cell Biophysics at the Technical University of Munich (TUM) within the TUM School of Natural Sciences . His research focuses on cellular biophysics , particularly the mechanical properties of cytoskeletal networks and self-organization mechanisms in biological systems, with applications in biomimetic materials and organoid modeling. Research Areas : Cytoskeletal mechanics, active matter systems, organoid morphogenesis, integrin signaling, synthetic cell models Techniques : Microrheology, in vitro reconstitution, microfluidics, advanced imaging His work has produced over 100 publications in Nature, Science, PNAS , and Physical Review Letters , with recent emphasis on pancreatic cancer organoids and artificial cell membranes . Key findings include: Discovery of topological excitations governing endothelial cell ordering Elucidation of PIP2/PIP3 regulation in integrin phase separation Development of 3D patterned organoid systems for drug screening Major awards include: ERC Synergy Grant (2018) ERC Advanced Grant (2012) ERC Starting Grant (2011) Berlin-Brandenburg Academy of Sciences Prize (2014) He serves as founding director of the Center for Functional Protein Assemblies (CPA) since 2015 and teaches biomechanics , biophysics , and protein assemblies at TUM. His lab investigates both fundamental biophysical principles and their medical applications in cancer and cardiovascular systems.

• Cellular Biophysics
• Molecular Biophysics
• Structural Biology
• +6 more

Ying Ge is a Professor at the University of Wisconsin–Madison, jointly appointed in the Department of Cell and Regenerative Biology and the Department of Chemistry. Her research integrates chemistry, biology, and medicine, focusing on advanced mass spectrometry-based proteomic and metabolomic technologies to address cardiovascular diseases. Education: B.S., Peking University (1997) Ph.D., Cornell University (2002) Ying Ge's work centers on developing ultra high-resolution mass spectrometry platforms for top-down proteomics and metabolomics, applied to systems biology studies of heart failure and regenerative medicine. Key projects include myofilament protein modification mapping, stem cell therapy evaluation, and biomarker discovery for cardiac conditions. The 15 most recent articles highlight her lab's methodological innovations (e.g., photocleavable surfactants, native mass spectrometry) and biological discoveries in AMPK structural heterogeneity, RBM20-mediated cardiotoxicity, and sarcomere-metabolism cross-talk during regeneration. These publications span proteomics, metabolomics, structural biology, and clinical applications.

• Biological Mass Spectrometry
• Proteomics
• Metabolomics
• +7 more

Dr. Darryl Dickerson is an Assistant Professor in the Department of Mechanical and Materials Engineering at Florida International University (FIU), part of the College of Engineering. His research focuses on mechanical characterization of biological interfaces, design of bioinspired materials, and advancing inclusive engineering education practices. He holds a Ph.D. (details not explicitly provided in text). Research Interests: Dr. Dickerson’s work bridges biomechanics and biomaterials engineering with social equity in education. Key areas include: Mechanical properties of biological interfaces (e.g., bone-cartilage junctions) Development of biomaterials for tissue repair using 3D printing and electrospinning Anti-marginalization strategies in engineering education, particularly for Black and Brown students Publications Trends: Recent work emphasizes dual themes: (1) Biomedical innovation through advanced material fabrication and (2) Inclusive pedagogy addressing systemic inequities in STEM education. Notable contributions include scaffold designs for osteochondral repair and frameworks for reducing microaggressions in team-based learning. Grants and Advising: No specific grants or advisees listed in the provided text. His work appears to be grant-funded through NIH/National Science Foundation pathways common in biomaterials and education research. Labs and Teams: While not explicitly stated, his research likely involves collaborations with FIU’s Center for Engineering and Computing’s diversity initiatives and biomaterials labs focusing on tissue engineering applications.

• Biomedical Engineering
• Mechanical Characterization of Biological Interfaces
• Bioinspired Materials Design
• +4 more

Amy Catherine Rowat is a full Professor in the Department of Integrative Biology and Physiology at UCLA's College of Letters and Science. She directs an interdisciplinary research program that integrates mechanobiology, microfluidics, cancer biophysics and food engineering to understand how physical forces shape cell behavior and to develop sustainable biotechnologies. Education & Affiliations: Professor, Department of Integrative Biology and Physiology, UCLA Member, UCLA College of Letters and Science Research Interests: Rowat's group deciphers how mechanical properties of cells and their nuclei influence disease progression and therapeutic response. Using high-throughput microfluidic deformability cytometry, her team discovered that cancer cells become stiffer and more invasive upon β-adrenergic signaling, linking stress hormones to metastatic potential. Parallel efforts focus on nuclear envelope mechanics, showing that histone H1.0 and transient nuclear deformation modulate chromatin structure and cell reprogramming. Beyond biomedicine, Rowat pioneers biophysical approaches for sustainable food production. She engineers edible scaffolds and emulsion-templated microcarriers to culture meat at scale, demonstrating spontaneous fusion of adipogenic and myogenic microtissues into marbled steak-like constructs. Recent Article Trends (2020-2025): Her latest publications reveal a cohesive trajectory: coupling mechanobiology to epigenetic regulation (viscoelastic matrix enhances chromatin remodeling), advancing single-cell mechanical phenotyping (optomagnetic arrays, high-throughput screens), translating findings to cancer therapy (β-blockers to sensitize chemotherapy) and expanding engineered foods (scalable cultured-meat bioprocessing). Funding & Awards: NIH R21 CA245667 (PI) – Repurposing beta-blockers to improve chemotherapy response (2021-2023) Laboratory & Teams: Rowat leads an active research laboratory at UCLA that trains graduate students and postdocs at the intersection of physics, engineering and biology. The lab maintains collaborations across UCLA Engineering, Jonsson Comprehensive Cancer Center, and external partners in food science and biotechnology companies.

• Mechanobiology
• Cancer biophysics
• Single-cell mechanics
• +6 more

Chris B. Schaffer is a Professor in the Meinig School of Biomedical Engineering at Cornell University, specializing in developing advanced optical techniques to study neurovascular dynamics in neurological diseases. His lab focuses on Alzheimer’s disease mechanisms, leveraging multiphoton microscopy and in vivo imaging to explore capillary stalling, cerebral blood flow deficits, and their cognitive impacts. He holds a Ph.D. in Physics from Harvard University and postdoctoral training in neuroscience at UC San Diego. Research interests include biomedical imaging instrumentation, neurodegenerative disease modeling, and science education innovation. Awards include AAAS Fellowship (2021), AIMBE Fellowship (2019), and multiple teaching accolades. His work bridges engineering and medicine, with contributions to spinal cord injury studies, epilepsy, and vascular contributions to dementia (VCID). Notable discoveries include identifying neutrophil-induced capillary stalls as a key Alzheimer’s disease mechanism and demonstrating cerebral blood flow improvements can restore memory in mouse models. His lab also develops educational tools emphasizing science as a discovery process, used in K-12 and university settings.

• Biomedical Imaging and Instrumentation
• Bioengineering
• Neuroscience
• +3 more

Professor Athina E Markaki serves as Professor of Materials & Biomedical Engineering in the Department of Engineering at the University of Cambridge, leading research in advanced biomaterials and tissue engineering solutions for regenerative medicine with emphasis on vascularization and tubular scaffold development for human conduit replacement. Her academic credentials include a Diploma in Metallurgical Engineering (8.6/10) from the National Technical University of Athens and a PhD in Materials Science from the University of Cambridge. Markaki's research program centers on vascularisation techniques for clinically relevant tissue dimensions and tubular scaffolds to replace diseased or damaged human conduits, integrating biomaterials science with regenerative medicine principles. Key applications span liver tissue engineering, neural crest-derived stem cell differentiation, and vascular graft development, with strong translational focus on orthopaedic and cardiovascular medical devices. Analysis of her recent publications reveals dominant trends in biomimetic scaffold design, particularly collagen-based tubular structures and hydrogel systems for vascularized tissue constructs. Her work demonstrates interdisciplinary convergence of AI-driven retinal assessment, glioblastoma modeling, and self-healing cementitious materials, with consistent emphasis on clinically applicable regenerative solutions for liver, bone, and neural tissues. Her distinguished scientific contributions are recognized by major awards: Rosetrees Trust 2017 Interdisciplinary Award European Research Council (ERC) Starting Grant (2010) Advanced EPSRC Fellowship (2005) De Montfort Award at SET for Britain National Event (2004) Young Scientist Prize 2003 (5th Euromech Solid Mechanics Conference) Multiple academic excellence awards from Greek foundations Markaki directs a well-funded research program including ERC and EPSRC grants, mentoring graduate students in tissue engineering while teaching core engineering curricula covering plastic deformation, fracture mechanics, and medical materials design. Her group maintains strong industry and clinical partnerships to advance regenerative technologies. Her laboratory, accessible via http://www-memti.eng.cam.ac.uk/, specializes in vascularized tissue constructs and tubular scaffolds using laser-based manufacturing, biomimetic design, and hydrogel engineering to address critical challenges in tissue replacement and disease modeling.

• Tissue Engineering
• Biomaterials
• Regenerative Medicine
• +3 more

Dr. Xin Zhou is an Oxford-Bristol Myers Squibb Fellow at the Department of Computer Science, University of Oxford. Her research integrates computational modeling, clinical data, and experimental findings to investigate cardiac disease mechanisms and develop human-based simulations for drug evaluation. BSc and MSc in Life Sciences, Beijing Normal University DPhil in Computational Biology, University of Oxford Her work focuses on multi-scale cardiac modeling , particularly in ischemic heart disease and heart failure, exploring ionic currents, tissue conduction, and organ-level dynamics. She develops electromechanical simulations to study cardiac alternans and arrhythmic risks, translating these into clinical applications for patient stratification and pharmaceutical testing. Recent publications emphasize in silico clinical trials , sex-specific cardiometabolic analysis, and Purkinje network modeling. Collaborative efforts with clinicians and pharmaceutical partners highlight her translational approach to regulatory science. Model of the Year 2024, BioModels EPSRC Impact Acceleration Account Microsoft Research Project Award Recognition Award, University of Oxford She supervises PhD and MSc students in computational cardiology, while serving on the editorial board of Frontiers in Physiology . Her current projects involve digital twinning and predictive cardiac safety models to reduce animal testing reliance.

• Computational Biology
• Health Informatics
• Cardiovascular Disease Modeling
• +3 more

Adam de la Zerda is an Associate Professor at Stanford University's Department of Structural Biology (School of Medicine) and Electrical Engineering (by courtesy). He develops advanced optical molecular imaging technologies combining nanoparticle contrast agents and adaptive OCT systems for cancer and ophthalmic disease research. Technion-Israel Institute of Technology (BSc, 2005) Stanford University (PhD, 2011) UC Berkeley (Postdoctoral Fellowship) Research Themes : Virtual biopsy using machine learning-enhanced OCT Gold nanorod-based molecular contrast agents Speckle noise reduction for cellular resolution Needle beam optical coherence tomography angiography His 15 most recent publications demonstrate technical innovations in: Metasurface optics for extended depth-of-field Spectral deconvolution of multiple contrast agents Speckle modulation for improved diagnostic clarity Noninvasive lymphatic system mapping Scientific Honors : Pew-Stewart Scholar for Cancer Research AFOSR Young Investigator NIH Early Independence Award Forbes 30 Under 30 (x2) Chan Zuckerberg BioHub Investigator His lab team has developed clinical prototypes including OcuBell Inc. 's ophthalmic imaging systems and Visby Medical 's diagnostic platforms. Current research spans from in vivo glycoprotein imaging to de novo biosensor development for real-time disease monitoring in awake animal models.

• Molecular Imaging
• Biomedical Imaging
• Optical Coherence Tomography
• +3 more